Focus: Frontier Medicines is a public biotechnology company focused on oncology drug discovery using a proprietary chemoproteomics platform. The company is in early-stage clinical development with a lean pipeline targeting precision medicine opportunities in solid tumors.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Stable — net -2 jobs in 30d
2 added, 4 removed. Backfill posture.
High-risk, high-science opportunity best suited for researchers and early-stage drug developers comfortable with platform validation work in a restructuring biotech.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Frontier Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Frontier Medicines's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Frontier Medicines reports promising lung cancer drug results in early trial - Seeking Alpha
Frontier Medicines reports promising lung cancer drug results in early trial Seeking Alpha
Frontier Medicines Names Aaron Weitzman, Mike Preigh and Joelle Lufkin to Leadership Team - citybiz
Frontier Medicines Names Aaron Weitzman, Mike Preigh and Joelle Lufkin to Leadership Team citybiz
Frontier Medicines Strengthens Leadership Team with Appointment of Three Drug Development Veterans - Business Wire
Frontier Medicines Strengthens Leadership Team with Appointment of Three Drug Development Veterans Business Wire
Frontier Medicines Strengthens Leadership Team with Appointment of Three Drug Development Veterans - Yahoo Finance
Frontier Medicines Strengthens Leadership Team with Appointment of Three Drug Development Veterans Yahoo Finance
After some ‘tough years,’ Frontier’s CEO is ramping up ambitions for precision med platform - Fierce Biotech
After some ‘tough years,’ Frontier’s CEO is ramping up ambitions for precision med platform Fierce Biotech
Frontier Medicines Adds Former Seagen CEO David Epstein to Board - citybiz
Frontier Medicines Adds Former Seagen CEO David Epstein to Board citybiz
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo